SinoMab BioScience Limited (HKG: 3681, SinoMab or the Company), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing…
Browsing: Sinomab BioScience Limited
Clinical Development Program for the Treatment of AD to be Initiated Shortly A Hong Kong-based biopharmaceutical company dedicated to the…
Speeding up Domestic Clinical Trials A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics…
A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological…
Accelerating Domestic Clinical Trials and Targeting the Blue Ocean of Asthma Drugs A Hong Kong-based biopharmaceutical company dedicated to the…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company…
SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development,…
Promote R&D and Marketing of Drug Candidates & Form Production and Commercialization Platform SinoMab BioScience Limited (“SinoMab” or the “Company”,…
Pipeline of Drug Candidates Has Vast Potential in the Future SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK),…